Treatment of patients with metastatic osteogenic sarcoma: A report from the childrens cancer study group

E. Morgan, E. Baum, W. A. Bleyer, N. Movassaghi, A. Provisor, B. Lampkin, J. Lukens, T. Griffin, H. White, C. Fryer

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

Fifty-three patients with metastatic osteogenic sarcoma were treated with vincristine high-dose methotrexate with citrovorum factor rescue, and cisplatin. Metastases were surgically removed in most patients, either prior to chemotherapy or following initial response to therapy. Among 29 previously treated patients, responses to initial chemotherapy included two complete remissions, six partial remissions, and eight patients with stable disease. Twenty-three patients were disease-free, six for > 12 months. Toxicity was moderate, but usually reversible. There were two toxic deaths and one unexplained death 48 hours following a dose of cisplatin.

Original languageEnglish (US)
Pages (from-to)661-664
Number of pages4
JournalCancer Treatment Reports
Volume68
Issue number4
StatePublished - 1984

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Treatment of patients with metastatic osteogenic sarcoma: A report from the childrens cancer study group'. Together they form a unique fingerprint.

  • Cite this

    Morgan, E., Baum, E., Bleyer, W. A., Movassaghi, N., Provisor, A., Lampkin, B., Lukens, J., Griffin, T., White, H., & Fryer, C. (1984). Treatment of patients with metastatic osteogenic sarcoma: A report from the childrens cancer study group. Cancer Treatment Reports, 68(4), 661-664.